Defense Health Program Department of Defense Kidney Cancer Research Program Funding Opportunities for Fiscal Year 2020 (FY20)

How to Apply: 

The FY20 Defense Appropriations Act provides funding to the Department of Defense Kidney Cancer Research Program (KCRP) to support research of exceptional scientific merit in the area of kidney cancer.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

 

The FY20 KCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website. 

 

Applications submitted to the FY20 KCRP Idea Development Award mechanism are encouraged to address one or more of the following Areas of Emphasis:

 

  • Treatments/Survivorship
  • Basic/Translational Science
  • Diagnostics/Prognostics/Biomarkers/Surveillance
  • Population-Based Studies
    • Noninvasive Interventions
    • Surgical Interventions
    • Therapeutic Development
    • Understanding and Managing Toxicity
    • Survivorship and Patient Experience
    • Genetics
    • Chromatin and Gene Regulation
    • Metabolism
    • Microenvironment and Immunology
    • Environmental Exposures (and/or Deployment-Related Exposures)
    • New Disease Model Systems
    • Rare Kidney Cancers
    • Mechanism of Response and Resistance
    • Prognosis
    • Biomarker Development
    • Novel Imaging Technologies
    • Liquid Biopsy
    • Microbiome
    • Disease Disparities
    • Screening and Early Detection
    • Surveillance
    • Outcome/Population-Based Studies
    • Environmental Exposures (and/or Deployment-Related Exposures)
    • Disease Disparities

 

https://cdmrp.army.mil/funding/kcrp

 

Academy of Kidney Cancer Investigators – Early-Career Investigator Award – Letter of Intent due August 5, 2020

Must be within 3 years of their last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equivalent, as of the full application submission deadline

Letter attesting to eligibility required

  • Supports addition of new Early-Career Investigators to the unique, interactive virtual academy that providing intensive mentoring, national networking, and a peer group for junior faculty.
  • Early-Career Investigators whose ability to commit to conducting kidney cancer research is limited by lack of resources or other overwhelming obstacles are encouraged to apply.
  • A Designated Mentor who is an experienced kidney cancer researcher with kidney cancer funding.
  • The Designated Mentor not required to be at the same institution as the Early-Career Investigator.
  • Preliminary data required.
  • Clinical trials allowed.
    • Maximum funding of $725,000 for direct costs (plus indirect costs).
    • Maximum period of performance 4 years.
    • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreements.

 

Concept Award – Letter of Intent due July 15, 2020

All Investigators at or above the level of postdoctoral fellow (or equivalent) are eligible

  • Supports highly innovative, untested, potentially groundbreaking concepts in kidney cancer
  • Emphasis on innovation
  • Clinical trials not allowed
  • Preliminary data not allowed
  • Blinded review
    • Maximum funding of $100,000 for direct costs (plus indirect costs)
    • Maximum period of performance 1 year
    • Indirect cost may be proposed in accordance with the institution’s negotiated rate agreement.

 

Translational Research Partnership Award – Letter of Intent due August 5, 2020

The Initiating Principal Investigator (PI) must be at or above the level of Assistant Professor or equivalent).

The Partnering PI must be at or above the level of Assistant Professor or equivalent. 

Postdoctoral fellows are not eligible to be Partnering PIs.

  • Supports partnerships between clinicians and laboratory scientists that accelerate ideas in kidney cancer into clinical applications.
  • Supports translational correlative studies
  • Preliminary data required
  • Clinical trials not allowed
  • Maximum funding of $750,000 for direct costs (plus indirect costs)
  • Maximum period of performance 3 years
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement

 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the KCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

 

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

External Deadline: 
Wednesday, July 15, 2020
Funding Source: 
External
Funding Level: 
Research